Methods of obtaining active antisense compounds
Patent
·
OSTI ID:1531599
Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.
- Research Organization:
- Isis Pharmaceuticals, Inc., Carlsbad, CA (United States); Univ. of Utah, Salt Lake City, UT (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG03-99ER62732
- Assignee:
- Isis Pharmaceuticals, Inc. (Carlsbad, CA); University of Utah Research Foundation (Salt Lake City, UT)
- Patent Number(s):
- 7,592,440
- Application Number:
- 10/686,317
- OSTI ID:
- 1531599
- Country of Publication:
- United States
- Language:
- English
Similar Records
Methods of obtaining active antisense compounds
Advanced surface-enhanced Raman gene probe systems and methods thereof
Method for performing site-specific affinity fractionation for use in DNA sequencing
Patent
·
2012
·
OSTI ID:1531738
Advanced surface-enhanced Raman gene probe systems and methods thereof
Patent
·
2000
·
OSTI ID:873496
Method for performing site-specific affinity fractionation for use in DNA sequencing
Patent
·
1998
·
OSTI ID:872290